Endomedix
3 known investors
Endomedix is developing PLEXimine, a technology platform based on polysaccharide chemistry that lets surgeons form structured medical devices in situ during procedures. The company focuses on biosurgery and related medical applications.
BiotechMedical DevicesNew Materials
Investors · 3
Frequently asked questions
- What does Endomedix do?
- Endomedix is developing PLEXimine, a technology platform based on polysaccharide chemistry that lets surgeons form structured medical devices in situ during procedures. The company focuses on biosurgery and related medical applications.
- Who are Endomedix's investors?
- Endomedix's investors include Central Texas Angel Network, Houston Angel Network, Keiretsu Forum.